Achiko Logo cropped.jpg
Achiko Appoints New Chief Financial Officer and Announces Changes to Senior Team
04 mai 2021 07h30 HE | Achiko AG
Appoints Robert Rieder as Chief Financial OfficerChief Operating Officer Chris Young to Retire Focus on Product Development, Lowering Cost Profile and Improved Alignment of Resources ZURICH,...
Achiko Logo cropped.jpg
Achiko’s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration
29 avr. 2021 07h30 HE | Achiko AG
Achiko AG’s Joint Venture Partner PT Indonesia Farma Medis (IFM) Obtains Medical Device Distribution CertificateAchiko Subsequently Commenced Product Registration with its Partners with a View to...
Logo.jpg
ProPhase Labs to Provide COVID-19 Testing for Oyster Bay Township in New York
22 avr. 2021 08h30 HE | ProPhase Labs, Inc.
ProPhase Labs Will Offer State-Of-The-Art Testing to Aid Oyster Bay Community in Reopening GARDEN CITY, NY, April 22, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified...
LifeLabs partners wi
LifeLabs partners with Fionet Rapid Response Group to implement COVID-19 rapid diagnostic testing services
15 avr. 2021 10h16 HE | LifeLabs
Toronto, Ontario, April 15, 2021 (GLOBE NEWSWIRE) -- LifeLabs, Canada’s largest provider of laboratory services, is pleased to sign an exclusive agreement with Fionet Rapid Response Group Inc.,...
p5c92dd987fc0c40004d9806b_1.png
Progressive Care Achieves Record COVID-19 Testing Revenues
05 avr. 2021 07h00 HE | Progressive Care, Inc.
MIAMI, FL, April 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company,...
LifeLabs and Multiplex Genomics Announce Partnership to Increase COVID-19 Testing Capacity and Track COVID-19 Variants
16 févr. 2021 13h00 HE | LifeLabs
Toronto, ON, Feb. 16, 2021 (GLOBE NEWSWIRE) -- LifeLabs and Multiplex Genomics are proud to announce a strategic alliance that will greatly expand Canada’s capacity to test and track COVID-19 and...
Achiko Logo cropped.jpg
Achiko Establishes Joint Venture with PT Indonesia Farma Medis for Production and Distribution of its Test Platform for Covid-19 in Indonesia
12 févr. 2021 07h30 HE | Achiko AG
Achiko Signs Agreement with PT Indonesia Farma Medis to Establish a New Joint Venture, including a Contract with PT Mitra Asa Pratama and a Memorandum of Understanding with PT Pharos Indonesia,...
Achiko Logo cropped.jpg
Achiko Concludes Phase 1 Study of Project Gumnuts for Covid-19 Testing
25 janv. 2021 07h30 HE | Achiko AG
Completion of Phase 1 Testing Demonstrates 91% Sensitivity and 85% SpecificityFurther Optimization Studies are Currently Being Performed and are Expected to Continue to Improve Results and Match WHO...
RelayMedicalLogo (3).jpg
Relay Medical and Fio Corporation Announce Launch of High-Throughput COVID-19 ‘Mobile Testing Toolkit’ Capable of Processing 100 Tests Per Hour
20 janv. 2021 03h00 HE | Relay Medical Corp.
Relay & Fio announce the launch of Fionet’s mobile, high-throughput COVID-19 rapid testing solution, for on-site rapid testing in high-volume settingsFionet’s high-throughput modular configuration...
RelayMedicalLogo (3).jpg
Relay Medical and Glow LifeTech Report on Successful Phase II Clinical Results For COVID-19 Treatment Candidate Based On Its MyCell Technology™
14 janv. 2021 16h15 HE | Relay Medical Corp.
Glow LifeTech has the exclusive rights for MyCell Technology™ in the United States, Canada and Mexico for one of the primary ingredients used in ArtemiC™, a COVID-19 Treatment Candidate with...